Novel role of TLR4 in NAFLD development: Modulation of metabolic enzymes expression

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1851, Issue 10, 2015, Pages 1353-1359

  Ferreira, Darkiane Fernandes ^a   Fiamoncini, Jarlei ^b   Prist, Iryna Hirata ^a   Ariga, Suely Kubo ^a   De Souza, Heraldo Possolo ^a   De Lima, Thais Martins ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acyl carnitine profile; Fatty acid oxidation; High fat diet; LDL receptor knockout; Non alcoholic fatty liver disease; Toll like receptor 4

Indexed keywords

ACETYL COENZYME A ACYLTRANSFERASE; ACYL COENZYME A OXIDASE; ACYLCARNITINE; APOLIPOPROTEIN B100; CARNITINE PALMITOYLTRANSFERASE I; CHOLESTEROL; FATTY ACID; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE 1; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE 4; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN RECEPTOR; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; MITOCHONDRIAL TRIFUNCTIONAL PROTEIN ALPHA SUBUNIT; MITOCHONDRIAL TRIFUNCTIONAL PROTEIN BETA SUBUNIT; PEROXISOMAL BIFUNCTIONAL ENZYME; TOLL LIKE RECEPTOR 4; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; FAT INTAKE; TLR4 PROTEIN, MOUSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENIC DIET; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; FATTY ACID OXIDATION; GENE EXPRESSION; GENOTYPE; LIPID DIET; LIPID LIVER LEVEL; LIPID STORAGE; MALE; METABOLIC REGULATION; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; ADVERSE EFFECTS; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; FAT INTAKE; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHARMACOLOGY;

ANIMALIA; MUS;

ANIMALS; CHOLESTEROL; DIET, ATHEROGENIC; DIETARY FATS; FATTY ACIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MICE; MICE, KNOCKOUT; NON-ALCOHOLIC FATTY LIVER DISEASE; TOLL-LIKE RECEPTOR 4; TRIGLYCERIDES;

EID: 84938125072     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2015.07.002     Document Type: Article

References (36)

1. B.A. Neuschwander-Tetri, and S.H. Caldwell Nonalcoholic steatohepatitis: summary of an AASLD single topic conference Hepatology 37 2003 1202 1219
2. E. Vanni, E. Bugianesi, A. Kotronen, S. De Minicis, H. Yki-Järvinen, and G. Svegliati-Baroni From the metabolic syndrome to NAFLD or vice versa? Dig. Liver Dis. 42 2010 320 330
3. J.B. Soares, P. Pimentel-Nunes, R. Roncon-Albuquerque, and A. Leite-Moreira The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases Hepatol. Int. 4 2010 659 672
4. S. Thuy, R. Ladurner, V. Volynets, S. Wagner, S. Strahl, A. Königsrainer, K.P. Maier, S.C. Bischoff, and I. Bergheim Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake J. Nutr. 138 2008 1452 1455
5. R. Gill, A. Tsung, and T. Billiar Linking oxidative stress to inflammation: toll-like receptors Free Radic. Biol. Med. 48 2010 1121 1132
6. H. Shi, M.V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J.S. Flier TLR4 links innate immunity and fatty acid-induced insulin resistance J. Clin. Invest. 116 2006 3015 3025
7. J.Y. Lee, K.H. Sohn, S.H. Rhee, and D. Hwang Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4 J. Biol. Chem. 276 2001 16683 16689
8. J.Y. Lee, A. Plakidas, W.H. Lee, A. Heikkinen, P. Chanmugam, G. Bray, and D.H. Hwang Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids J. Lipid Res. 44 2003 479 486
9. I.T. De Almeida, H. Cortez-Pinto, G. Fidalgo, D. Rodrigues, and M.E. Camilo Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis Clin. Nutr. 21 2002 219 223
10. J. Jawień, P. Nastałek, and R. Korbut Mouse models of experimental atherosclerosis J. Physiol. Pharmacol. 55 2004 503 517
11. A. Funke, M. Schreurs, M. Aparicio-Vergara, F. Sheedfar, N. Gruben, N.J. Kloosterhuis, R. Shiri-Sverdlov, A.K. Groen, B. Van De Sluis, M.H. Hofker, and D.P. Koonen Cholesterol-induced hepatic inflammation does not contribute to the development of insulin resistance in male LDL receptor knockout mice Atherosclerosis 232 2014 390 396
12. K.R. Coenen, and A.H. Hasty Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice Am. J. Physiol. Endocrinol. Metab. 293 2007 E492 E499
13. S. Subramanian, L. Goodspeed, S. Wang, J. Kim, L. Zeng, G.N. Ioannou, W.G. Haigh, M.M. Yeh, K.V. Kowdley, K.D. O'Brien, S. Pennathur, and A. Chait Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice J. Lipid Res. 52 2011 1626 1635
14. J. Folch, M. Lees, and G.H. Sloane Stanley A simple method for the isolation and purification of total lipids from animal tissues J. Biol. Chem. 226 1957 497 509
15. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(- delta delta C(T)) method Methods 25 2001 402 408
16. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res. 29 2001 e45
17. D. Ye, F.Y. Li, K.S. Lam, H. Li, W. Jia, Y. Wang, K. Man, C.M. Lo, X. Li, and A. Xu Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice Gut 61 2012 1058 1067
18. T. Csak, A. Velayudham, I. Hritz, J. Petrasek, I. Levin, D. Lippai, D. Catalano, P. Mandrekar, A. Dolganiuc, E. Kurt-Jones, and G. Szabo Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice Am. J. Physiol. Gastrointest. Liver Physiol. 300 2011 G433 G441
19. C.A. Rivera, P. Adegboyega, N. Van Rooijen, A. Tagalicud, M. Allman, and M. Wallace Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis J. Hepatol. 47 2007 571 579
20. T. Tsujimoto, H. Kawaratani, T. Kitazawa, M. Uemura, and H. Fukui Innate immune reactivity of the ileum-liver axis in nonalcoholic steatohepatitis Dig. Dis. Sci. 57 2012 1144 1151
21. U. Vespasiani-Gentilucci, S. Carotti, G. Perrone, C. Mazzarelli, G. Galati, A. Onetti-Muda, A. Picardi, and S. Morini Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD Liver Int. 35 2 2015 569 581
22. J. Liu, Z.J. Zhuang, D.X. Bian, X.J. Ma, Y.H. Xun, W.J. Yang, Y. Luo, Y.L. Liu, L. Jia, Y. Wang, M.L. Zhu, D.W. Ye, G. Zhou, G.Q. Lou, and J.P. Shi The toll-like receptor-4 signalling in the progression of non-alcoholic fatty liver disease induced by high fat and high fructose diet in mice Clin. Exp. Pharmacol. Physiol. 41 7 2014 482 488
23. P. Nagarajan, M.J. Mahesh Kumar, R. Venkatesan, S.S. Majundar, and R.C. Juyal Genetically modified mouse models for the study of nonalcoholic fatty liver disease World J. Gastroenterol. 18 2012 1141 1153
24. Y. Ding, S. Subramanian, V.N. Montes, L. Goodspeed, S. Wang, C. Han, A.S. Teresa, J. Kim, K.D. O'Brien, and A. Chait Toll-like receptor 4 deficiency decreases atherosclerosis but does not protect against inflammation in obese low-density lipoprotein receptor-deficient mice Arterioscler. Thromb. Vasc. Biol. 32 2012 1596 1604
25. A.A. Wendel, T.M. Lewin, and R.A. Coleman Glycerol-3-phosphate acyltransferases: rate limiting enzymes of triacylglycerol biosynthesis Biochim. Biophys. Acta 1791 2009 501 506
26. D. Gruffat, D. Durand, B. Graulet, and D. Bauchart Regulation of VLDL synthesis and secretion in the liver Reprod. Nutr. Dev. 36 1996 375 389
27. S. Eaton, K. Bartlett, and M. Pourfarzam Mammalian mitochondrial beta-oxidation Biochem. J. 320 Pt 2 1996 345 357
28. J.D. Mcgarry, and N.F. Brown The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis Eur. J. Biochem. 244 1997 1 14
29. J.K. Reddy Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis Am. J. Physiol. Gastrointest. Liver Physiol. 281 2001 G1333 G1339
30. J.S. Campbell, K.J. Riehle, J.T. Brooling, R.L. Bauer, C. Mitchell, and N. Fausto Proinflammatory cytokine production in liver regeneration is Myd88-dependent, but independent of Cd14, Tlr2, and Tlr4 J. Immunol. 176 2006 2522 2528
31. L.A. Videla, R. Rodrigo, J. Araya, and J. Poniachik Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease Free Radic. Biol. Med. 37 2004 1499 1507
32. K. Mehta, D.H. Van Thiel, N. Shah, and S. Mobarhan Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants Nutr. Rev. 60 2002 289 293
33. S. Tachibana, X. Zhang, K. Ito, Y. Ota, A.M. Cameron, G.M. Williams, and Z. Sun Interleukin-6 is required for cell cycle arrest and activation of DNA repair enzymes after partial hepatectomy in mice Cell Biosci. 4 2014 6
34. B. Saad, K. Frei, F.A. Scholl, A. Fontana, and P. Maier Hepatocyte-derived interleukin-6 and tumor-necrosis factor alpha mediate the lipopolysaccharide-induced acute-phase response and nitric oxide release by cultured rat hepatocytes Eur. J. Biochem. 229 1995 349 355
35. A.L. Carey, G.R. Steinberg, S.L. Macaulay, W.G. Thomas, A.G. Holmes, G. Ramm, O. Prelovsek, C. Hohnen-Behrens, M.J. Watt, D.E. James, B.E. Kemp, B.K. Pedersen, and M.A. Febbraio Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase Diabetes 55 2006 2688 2697
36. F. Hong, S. Radaeva, H.N. Pan, Z. Tian, R. Veech, and B. Gao Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease Hepatology 40 2004 933 941